CORE-016: MICROSCOPY SHARED RESOURCE (MSR) PROJECT SUMMARY / ABSTRACT The Microscopy Shared Resource (MSR) is a strategically important research facility for OSUCCC members, providing transmission electron microscopy, scanning electron microscopy, two-photon confocal microscopy, confocal microscopy, widefield light microscopy, stereomicroscopy and live cell imaging. The MSR provides the expertise for microscopy consultation and training for investigators so that they can use the instruments 24 hours per day, 7 days a week, using key-card access. Alternatively, the MSR has available staff to assist investigators with more complex needs. Training and instruments also are available for sample preparation.
The Specific Aims are of the MSR are: 1) to provide a means for the OSUCCC research community to obtain publication quality, high-resolution images of their cancer research for use in manuscripts and grant applications; 2) to provide training to investigators for independent use of the instruments; and 3) to provide education and consultation opportunities to OSUCCC researchers for improved sample preparation and imaging. During the last grant period, the MSR provided approximately 14,263 hours of service to 116 OSUCCC program members representing all five OSUCCC research programs (Cancer Control, Leukemia Research, Molecular Biology and Cancer Genetics, Molecular Carcinogenesis and Chemoprevention, and Translational Therapeutics), contributed to 124 publications by OSUCCC members, including 9 with journal impact factors >10 and supported 60 awards, the vast majority of which were from the NCI (1 F31, 1 K12, 1 K24, 6 P01s, 2 P50s, 30 R01s, 14 R21s, 1 R37, 1 T32, and 3 U01s). Future plans for the MSR include new live cell imaging, super-resolution light microscopy and confocal capabilities. The MSR is supported by outstanding institutional resources obtained by leveraging extensive partnerships with the OSUCCC, OSU Colleges, the OSU Office of Research and grants from the State of Ohio, all totaling $1,768,341 over the prior grant period. As such, the MSR seeks only 11.2% budgetary support from CCSG funds. The Microscopy Shared Resource is part of the Diagnostics Grouping.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-42
Application #
9390855
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Sprague, Leslee; Lee, Joel M; Hutzen, Brian J et al. (2018) High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy. Viruses 10:
Nakashima, Hiroshi; Alayo, Quazim A; Penaloza-MacMaster, Pablo et al. (2018) Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep 8:208
Coss, Christopher C; Clinton, Steven K; Phelps, Mitch A (2018) Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy? Clin Cancer Res 24:5787-5789
Rogers, Kerry A; Huang, Ying; Ruppert, Amy S et al. (2018) Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia. Blood 132:1568-1572
Eisfeld, Ann-Kathrin; Kohlschmidt, Jessica; Mrózek, Krzysztof et al. (2018) Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. Leukemia 32:1338-1348
Burton, Jenna H; Mazcko, Christina; LeBlanc, Amy et al. (2018) NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma. Clin Cancer Res 24:5830-5840
Salzer, Wanda L; Burke, Michael J; Devidas, Meenakshi et al. (2018) Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. Cancer 124:1150-1159
Yu, Peter Y; Lopez, Gonzalo; Braggio, Danielle et al. (2018) miR-133a function in the pathogenesis of dedifferentiated liposarcoma. Cancer Cell Int 18:89
Eisfeld, Ann-Kathrin; Kohlschmidt, Jessica; Mrózek, Krzysztof et al. (2018) NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. Leukemia 32:2536-2545
Ghoussaini, Maya; Edwards, Stacey L; Michailidou, Kyriaki et al. (2018) Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun 9:16193

Showing the most recent 10 out of 2602 publications